Dipeptidyl peptidase

Results: 124



#Item
101August 28, 2012 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd.  Launch of TENELIA® 20mg Tablets

August 28, 2012 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Launch of TENELIA® 20mg Tablets

Add to Reading List

Source URL: www.mt-pharma.co.jp

Language: English - Date: 2012-08-27 03:43:16
102June 29, 2012 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd.  Marketing and Manufacturing Approval Received for TENELIA® 20mg Tablets

June 29, 2012 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Marketing and Manufacturing Approval Received for TENELIA® 20mg Tablets

Add to Reading List

Source URL: www.mt-pharma.co.jp

Language: English - Date: 2012-09-04 21:13:37
103February 26, 2013 Press Release Mitsubishi Tanabe Pharma Corporation TENELIA® 20mg tablets, a Treatment for Type 2 Diabetes Mellitus Application for Partial Change in Indications for Combination Therapy

February 26, 2013 Press Release Mitsubishi Tanabe Pharma Corporation TENELIA® 20mg tablets, a Treatment for Type 2 Diabetes Mellitus Application for Partial Change in Indications for Combination Therapy

Add to Reading List

Source URL: www.mt-pharma.co.jp

Language: English - Date: 2013-12-11 23:08:01
104HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA® (sitagliptin) Tablets Initia

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA® (sitagliptin) Tablets Initia

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-10-22 15:47:59
10597627XX   HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA.

97627XX HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA.

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:10:45
106Merck Pipeline July 31, 2014 Merck Pipeline as of July 31, 20141 Phase 2

Merck Pipeline July 31, 2014 Merck Pipeline as of July 31, 20141 Phase 2

Add to Reading List

Source URL: www.merck.com

Language: English - Date: 2014-08-08 16:37:50
107HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRADJENTA safely and effectively. See full prescribing information for TRADJENTA. Tradjenta® (linagliptin) tablets

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRADJENTA safely and effectively. See full prescribing information for TRADJENTA. Tradjenta® (linagliptin) tablets

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-05-27 14:10:03
108

PDF Document

Add to Reading List

Source URL: media.wiley.com

Language: English - Date: 2013-08-27 13:18:00
109Fact Sheet  DPP-4 Inhibitors: Incretin-Based Medicine Type 2 Diabetes

Fact Sheet DPP-4 Inhibitors: Incretin-Based Medicine Type 2 Diabetes

Add to Reading List

Source URL: www.hormone.org

Language: English - Date: 2013-05-20 12:16:35
110INSTITUT NATIONAL D’ASSURANCE MALADIE-INVALIDITE SERVICE DES SOINS DE SANTE Comité d’ évaluation des pratiques médicales en matière de médicaments

INSTITUT NATIONAL D’ASSURANCE MALADIE-INVALIDITE SERVICE DES SOINS DE SANTE Comité d’ évaluation des pratiques médicales en matière de médicaments

Add to Reading List

Source URL: www.riziv.fgov.be

Language: English - Date: 2012-12-05 08:42:10